-
HEALTH CARE UTILIZATION DIFFERENCES BETWEEN MEDICARE ADVANTAGE AND STANDALONE PART D PLANS IN MEDICARE BENEFICIARIES WITH CANCER
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE METHODOLOGY FOR ECONOMIC EVALUATION OF CLINICAL AI: COST-EFFECTIVENESS OF AN IMAGING ALGORITHM FOR INCIDENTAL DETECTION OF EMPHYSEMA
Mar 18, 2026, 21:38 PM -
ARE MEDICARE’S NEGOTIATED PRICES FOR APIXABAN AND RIVAROXABAN CONSISTENT WITH VALUE BASED PRICES? EVIDENCE FROM A SYSTEMATIC REVIEW OF U.S. COST-EFFECTIVENESS ANALYSES
Mar 18, 2026, 21:38 PM -
EFFECT OF ANTIHYPERTENSIVE USE ON FALL RISK
Mar 18, 2026, 21:38 PM -
USE OF A NEW INSTRUMENT TO ASSESS HEALTH-RELATED QUALITY OF LIFE IN CHILDREN 0-3 YEARS OF AGE DURING HOSPITALIZATION DUE TO ROTAVIRUS GASTROENTERITIS IN THE US
Mar 18, 2026, 21:38 PM -
REPORTING OF STUDY DETAILS IN ABSTRACTS: INFORMATIVE FOR ARTIFICIAL INTELLIGENCE (AI) OR UNDERWHELMING?
Mar 18, 2026, 21:38 PM -
BRIDGING EVIDENCE AND ACCESS: SURVEY-BASED INSIGHTS INTO HOW BIOPHARMACEUTICAL MANUFACTURERS DEVELOP AND SHARE HCEI RESOURCES
Mar 18, 2026, 21:38 PM -
IMPACT OF TELEMEDICINE ENCOUNTERS ON SURVIVAL OUTCOMES: A TIME-VARYING COX ANALYSIS USING EHR-DERIVED DATA
Mar 18, 2026, 21:38 PM -
INDIVIDUAL PREFERENCES FOR UPPER EXTREMITY PROSTHETICS ALONG A USER-COMPLEXITY FRAMEWORK: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
THE VALUE VOCABULARY: AN ANALYSIS OF SOCIETAL TERMS IN CDA-AMC AND INESSS HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING
Mar 18, 2026, 21:38 PM -
WHEN HYPERTENSION REACHES THE HOSPITAL: PROFILING PATIENTS ADMITTED WITH HYPERTENSION AS A PRIMARY DIAGNOSIS IN CHILE’S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
EXPLORING PHYSICIANS’ PERSPECTIVES ON BARRIERS TO ENGAGING PATIENTS WITH RARE DISEASES AND/OR THEIR CAREGIVERS IN SHARED DECISION-MAKING IN THE UNITED STATES (US): FINDINGS FROM A CROSS-SECTIONAL SURVEY
Mar 18, 2026, 21:38 PM -
DEFINING TREATMENT TOLERABILITY FROM THE PATIENT’S PERSPECTIVE: A MIXED-METHODS ANALYSIS OF THE CANCER EXPERIENCE REGISTRY
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF RSV MATERNAL IMMUNIZATION [RSVPREF] IN THE DOMINICAN REPUBLIC: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
IMPACT OF PD-1 AND PD-L1 INHIBITORS ON PATIENT-REPORTED OUTCOMES IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
GEOSPATIAL EQUITY AND ECONOMIC IMPLICATIONS OF HEALTH DEVELOPMENT OFFICES IN HUNGARY
Mar 18, 2026, 21:38 PM -
LEVERAGING ARTIFICIAL INTELLIGENCE TO EXPEDITE DOSSIER DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF GENERATIVE AI ASSISTANT TOOLS ACROSS HEALTH ECONOMICS AND OUTCOMES RESEARCH WORKFLOWS: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
COST SAVINGS OF AN AI-ENABLED DIGITAL TWIN PROGRAM IN PREDIABETES AND HEALTHY WEIGHT MANAGEMENT
Mar 18, 2026, 21:38 PM -
USE ARTIFICIAL INTELLIGENCE TO PREDICT REGULATORY APPROVAL BASED ON PHASE III ONCOLOGY CLINICAL TRIAL PUBLICATIONS
Mar 18, 2026, 21:38 PM
